Estimations des analystes de Wall Street pour Avanos Medical, Inc. (AVNS): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 1 |
| Conserver | 6 |
| Vente | 1 |
| Vente forte | 0 |
| Analystes au total | 8 |
| Note moyenne (1-5) | 0.00 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-08-10 | $0.16 | ||
| 2026-05-05 | $0.22 | $0.16 | +37.5% |
| 2026-02-24 | $0.29 | $0.24 | +20.8% |
| 2025-11-05 | $0.22 | $0.12 | +83.3% |
| 2025-08-05 | $0.17 | $0.18 | -5.6% |
| 2025-05-06 | $0.26 | $0.19 | +36.8% |
| 2025-02-26 | $0.43 | $0.40 | +7.5% |
| 2024-10-30 | $0.36 | $0.36 | +0.0% |
Ratios de valorisation
| Prix / Valeur comptable | 1.48 |
| EV / EBITDA | -57.57 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $566.2M | $611.6M | $652.3M | $697.6M | $714.8M | $744.6M | $684.1M | $673.3M | $687.8M | $701.2M |
| Coût des Ventes | $269.0M | $274.7M | $261.4M | $295.4M | $324.2M | $364.7M | $289.9M | $293.6M | $306.5M | $352.2M |
| Marge Brute | $297.2M | $336.9M | $390.9M | $402.2M | $390.6M | $379.9M | $394.2M | $379.7M | $381.3M | $349.0M |
| R&D | $38.4M | $38.2M | $41.8M | $37.7M | $34.9M | $32.3M | $30.6M | $27.2M | $26.2M | $23.1M |
| Frais Généraux | $328.2M | $314.7M | $314.2M | $369.9M | $284.8M | $260.8M | $323.1M | $287.5M | $315.1M | $218.3M |
| Charges Opérationnelles | $366.6M | $352.9M | $356.0M | $407.6M | $319.7M | $293.1M | $352.3M | $314.7M | $341.3M | $410.6M |
| Résultat Opérationnel | -$69.4M | -$16.0M | $34.9M | -$5.4M | $70.9M | $86.8M | $41.9M | $65.0M | $40.0M | -$61.6M |
| EBITDA | -$65.5M | -$600000 | $37.0M | -$12.1M | -$2.0M | $48.9M | $77.8M | $50.6M | -$345.6M | -$33.2M |
| Charges d'Intérêt | $32.7M | $31.6M | $26.4M | $15.0M | $15.6M | $3.3M | $10.0M | $15.0M | $12.2M | $4.0M |
| Résultat Avant Impôts | -$139.2M | -$72.2M | -$18.1M | -$64.0M | -$60.5M | $7.3M | $26.7M | -$7.9M | -$403.3M | -$66.2M |
| Impôts | -$55.9M | -$40.1M | -$9.6M | -$18.1M | -$33.3M | $1.0M | $5.2M | $2.0M | -$17.0M | $1.7M |
| Résultat Net | $39.8M | $79.3M | $57.5M | -$45.9M | -$27.2M | $6.3M | $50.5M | -$61.8M | -$392.1M | -$67.9M |
| BPA | $0.85 | $1.69 | $1.22 | $-0.96 | $-0.57 | $0.13 | $1.08 | $-1.33 | $-8.53 | $-1.46 |
| BPA Dilué | $0.85 | $1.69 | $1.22 | $-0.96 | $-0.57 | $0.13 | $1.07 | $-1.33 | $-8.53 | $-1.46 |
| Actions en Circulation (Diluées) | $47.0M | $46.8M | $47.2M | $47.6M | $47.8M | $48.6M | $47.3M | $46.6M | $46.0M | $46.4M |
Prix
| Prix | $24.99 |
| Capitalisation | $1.2B |
| Bourse | NYSE |
| Pays | US |
Entreprises liées: AORT · AXGN · CVSA · ITGR · LIVN · VREX
Explorer le secteur: Healthcare · Medical - Devices
Plus de sections de AVNS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions